Strategic Assessment of the Middle EAST Biologics Contract...

σε πρόσθεσε στο άλλο

2025-12-29 07:05:19 - Μετάφραση -

Strategic Assessment of the Middle EAST Biologics Contract Manufacturing Market Competitive Landscape

The Middle EAST Biologics Contract Manufacturing Market was valued at USD 1.5 billion in 2024 and is projected to reach USD 3.8 billion by 2034, registering a CAGR of 9.5%. This growth trajectory is underpinned by several key factors, including increasing demand for biologics, advancements in biomanufacturing technologies, and a growing emphasis on outsourcing among pharmaceutical companies....

0 Σχόλια 0 Μοιράστηκε 723 Views 0 Προεπισκόπηση